<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35115501</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2041-1723</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nature communications</Title>
          <ISOAbbreviation>Nat Commun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice.</ArticleTitle>
        <Pagination>
          <StartPage>646</StartPage>
          <MedlinePgn>646</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">646</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-28204-z</ELocationID>
        <Abstract>
          <AbstractText>Efficacy of monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor (calcitonin receptor-like receptor/receptor activity modifying protein-1, CLR/RAMP1) implicates peripherally-released CGRP in migraine pain. However, the site and mechanism of CGRP-evoked peripheral pain remain unclear. By cell-selective RAMP1 gene deletion, we reveal that CGRP released from mouse cutaneous trigeminal fibers targets CLR/RAMP1 on surrounding Schwann cells to evoke periorbital mechanical allodynia. CLR/RAMP1 activation in human and mouse Schwann cells generates long-lasting signals from endosomes that evoke cAMP-dependent formation of NO. NO, by gating Schwann cell transient receptor potential ankyrin 1 (TRPA1), releases ROS, which in a feed-forward manner sustain allodynia via nociceptor TRPA1. When encapsulated into nanoparticles that release cargo in acidified endosomes, a CLR/RAMP1 antagonist provides superior inhibition of CGRP signaling and allodynia in mice. Our data suggest that the CGRP-mediated neuronal/Schwann cell pathway mediates allodynia associated with neurogenic inflammation, contributing to the algesic action of CGRP in mice.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>De Logu</LastName>
            <ForeName>Francesco</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Nassini</LastName>
            <ForeName>Romina</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Headache Center, Careggi University Hospital, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Hegron</LastName>
            <ForeName>Alan</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-7588-9209</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Landini</LastName>
            <ForeName>Lorenzo</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-3933-2497</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jensen</LastName>
            <ForeName>Dane D</ForeName>
            <Initials>DD</Initials>
            <Identifier Source="ORCID">0000-0001-6540-2375</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bluestone Center for Clinical Research, New York University College of Dentistry, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Latorre</LastName>
            <ForeName>Rocco</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ding</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Columbia University, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marini</LastName>
            <ForeName>Matilde</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-2199-2905</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Souza Monteiro de Araujo</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0003-1115-725X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramírez-Garcia</LastName>
            <ForeName>Paulina</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Drug Discovery Biology Theme and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Whittaker</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Drug Discovery Biology Theme and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Retamal</LastName>
            <ForeName>Jeffri</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Drug Discovery Biology Theme and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Titiz</LastName>
            <ForeName>Mustafa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Innocenti</LastName>
            <ForeName>Alessandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Plastic and Reconstructive Microsurgery - Careggi University Hospital, Florence, 50139, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Davis</LastName>
            <ForeName>Thomas P</ForeName>
            <Initials>TP</Initials>
            <AffiliationInfo>
              <Affiliation>Drug Discovery Biology Theme and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Veldhuis</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-8902-9365</Identifier>
            <AffiliationInfo>
              <Affiliation>Drug Discovery Biology Theme and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmidt</LastName>
            <ForeName>Brian L</ForeName>
            <Initials>BL</Initials>
            <Identifier Source="ORCID">0000-0002-2409-8984</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bluestone Center for Clinical Research, New York University College of Dentistry, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience and Physiology and Neuroscience Institute, School of Medicine, New York University, New York, NY, 10010, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bunnett</LastName>
            <ForeName>Nigel W</ForeName>
            <Initials>NW</Initials>
            <Identifier Source="ORCID">0000-0003-3367-0644</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, 10010, USA. nwb2@nyu.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience and Physiology and Neuroscience Institute, School of Medicine, New York University, New York, NY, 10010, USA. nwb2@nyu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Geppetti</LastName>
            <ForeName>Pierangelo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3797-8371</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, Italy. pierangelo.geppetti@unifi.it.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Headache Center, Careggi University Hospital, Florence, 50139, Italy. pierangelo.geppetti@unifi.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DE026806</GrantID>
            <Acronym>DE</Acronym>
            <Agency>NIDCR NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DE029951</GrantID>
            <Acronym>DE</Acronym>
            <Agency>NIDCR NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK118971</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS102722</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Commun</MedlineTA>
        <NlmUniqueID>101528555</NlmUniqueID>
        <ISSNLinking>2041-1723</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058286">Calcitonin Receptor-Like Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C545502">RAMP1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058262">Receptor Activity-Modifying Protein 1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000074025">TRPA1 Cation Channel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>31C4KY9ESH</RegistryNumber>
          <NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>JHB2QIZ69Z</RegistryNumber>
          <NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058286" MajorTopicYN="N">Calcitonin Receptor-Like Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006930" MajorTopicYN="N">Hyperalgesia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058262" MajorTopicYN="N">Receptor Activity-Modifying Protein 1</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074025" MajorTopicYN="N">TRPA1 Cation Channel</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>N.W.B. is a founding scientist of Endosome Therapeutics Inc. P.G. is a member of the Scientific Advisory Board of Endosome Therapeutics Inc. The laboratory of N.V. and M.W. has been funded in-part by Endosome Therapeutics Inc. R.N., F.D.L. and P.G. are founding scientists of FloNext Srl. P.G. has been in advisory boards and/or received fees for lectures from Novartis, Amgen, TEVA, AbbVie. The remaining authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35115501</ArticleId>
        <ArticleId IdType="pmc">PMC8813987</ArticleId>
        <ArticleId IdType="doi">10.1038/s41467-022-28204-z</ArticleId>
        <ArticleId IdType="pii">10.1038/s41467-022-28204-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lewis T. Experiments Relating to Cutaneous Hyperalgesia and Its Spread Through Somatic Nerves. Clin. Sci. 1936;2:373–414.</Citation>
        </Reference>
        <Reference>
          <Citation>Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol. Rev. 2014;94:1099–1142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4187032</ArticleId>
            <ArticleId IdType="pubmed">25287861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geppetti P., Holzer P. Neurogenic Inflammation. Boca Raton (1996).</Citation>
        </Reference>
        <Reference>
          <Citation>Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999;51:159–212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10353985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol. Rev. 2014;94:265–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3929113</ArticleId>
            <ArticleId IdType="pubmed">24382888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La JH, et al.  Differential involvement of reactive oxygen species in a mouse model of capsaicin-induced secondary mechanical hyperalgesia and allodynia. Mol. Pain. 2017;13:1744806917713907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5466348</ArticleId>
            <ArticleId IdType="pubmed">28587509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ali Z, Meyer RA, Campbell JN. Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin. Pain. 1996;68:401–411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9121830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinclair SR, et al.  Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974) Br. J. Clin. Pharmacol. 2010;69:15–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830593</ArticleId>
            <ArticleId IdType="pubmed">20078608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat. Rev. Neurol. 2018;14:338–350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29691490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashina H. Migraine. N. Engl. J. Med. 2020;383:10.</Citation>
        </Reference>
        <Reference>
          <Citation>Doods H, Arndt K, Rudolf K, Just S. CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol. Sci. 2007;28:580–587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17963849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hostetler ED, et al.  In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. J. Pharmacol. Exp. Ther. 2013;347:478–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23975906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noseda R, et al.  Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia. 2020;40:229–240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7233263</ArticleId>
            <ArticleId IdType="pubmed">31856583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson KW, Morin SM, Wroblewski VJ, Johnson MP. Peripheral and central nervous system distribution of the CGRP neutralizing antibody [(125)I] galcanezumab in male rats. Cephalalgia. 2019;39:1241–1248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31003588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mogil JS, et al.  Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc. Natl. Acad. Sci. USA. 2005;102:12938–12943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1200271</ArticleId>
            <ArticleId IdType="pubmed">16118273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rea BJ, et al.  Peripherally administered calcitonin gene-related peptide induces spontaneous pain in mice: implications for migraine. Pain. 2018;159:2306–2317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6193822</ArticleId>
            <ArticleId IdType="pubmed">29994995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Logu F, et al.  Migraine-provoking substances evoke periorbital allodynia in mice. J. Headache Pain. 2019;20:18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6734434</ArticleId>
            <ArticleId IdType="pubmed">30764776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marone IM, et al.  TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice. Brain. 2018;141:2312–2328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6061846</ArticleId>
            <ArticleId IdType="pubmed">29985973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashina M, Hansen JM, BO AD, Olesen J. Human models of migraine - short-term pain for long-term gain. Nat. Rev. Neurol. 2017;13:713–724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28984313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipton RB, et al.  Cutaneous allodynia in the migraine population. Ann. Neurol. 2008;63:148–158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2729495</ArticleId>
            <ArticleId IdType="pubmed">18059010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann. Neurol. 2000;47:614–624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10805332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goadsby PJ, et al.  Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol. Rev. 2017;97:553–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5539409</ArticleId>
            <ArticleId IdType="pubmed">28179394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>May A, Burstein R. Hypothalamic regulation of headache and migraine. Cephalalgia. 2019;39:1710–1719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7164212</ArticleId>
            <ArticleId IdType="pubmed">31466456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLatchie LM, et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998;393:333–339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9620797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennerz JK, et al.  Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J. Comp. Neurol. 2008;507:1277–1299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18186028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckers HJ, Klooster J, Vrensen GF, Lamers WP. Ultrastructural identification of trigeminal nerve terminals in the pterygopalatine ganglion of rats: an anterograde tracing and immunohistochemical study. Brain Res. 1991;557:22–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1720994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L, Khan M, Mudge AW. Calcitonin gene-related peptide promotes Schwann cell proliferation. J. Cell Biol. 1995;129:789–796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2120445</ArticleId>
            <ArticleId IdType="pubmed">7730412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edvinsson JCA, et al.  C-fibers may modulate adjacent Adelta-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. J. Headache Pain. 2019;20:105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6852900</ArticleId>
            <ArticleId IdType="pubmed">31718551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toth CC, et al.  Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regeneration. J. Neuropathol. Exp. Neurol. 2009;68:326–337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5790422</ArticleId>
            <ArticleId IdType="pubmed">19225405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Logu F, et al.  Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice. Nat. Commun. 2017;8:1887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5709495</ArticleId>
            <ArticleId IdType="pubmed">29192190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Logu F., et al. Peripheral Nerve Resident Macrophages and Schwann Cells Mediate Cancer-induced Pain. Cancer. Res. 81, 3387–3401 (2021).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8260461</ArticleId>
            <ArticleId IdType="pubmed">33771895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdo H, et al.  Specialized cutaneous Schwann cells initiate pain sensation. Science. 2019;365:695–699.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31416963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensen D. D., et al. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief. Sci. Transl. Med.9, eaal3447 (2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6034632</ArticleId>
            <ArticleId IdType="pubmed">28566424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramírez-García PD, et al.  A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain. Nat. Nanotechnol. 2019;14:1150–1159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7765343</ArticleId>
            <ArticleId IdType="pubmed">31686009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yarwood RE, et al.  Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission. Proc. Natl. Acad. Sci. USA. 2017;114:12309–12314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5699040</ArticleId>
            <ArticleId IdType="pubmed">29087309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talavera K, et al.  Mammalian Transient Receptor Potential TRPA1 Channels: From Structure to Disease. Physiol. Rev. 2020;100:725–803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31670612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lassen LH, et al.  CGRP may play a causative role in migraine. Cephalalgia. 2002;22:54–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11993614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo S, et al.  Selectivity of commonly used inhibitors of clathrin-mediated and caveolae-dependent endocytosis of G protein–coupled receptors. Biochimica et Biophysica Acta (BBA) Biomembranes. 2015;1848:2101–2110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26055893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosaka K, et al.  Calcitonin gene-related peptide activates different signaling pathways in mesenteric lymphatics of guinea pigs. Am. J. Physiol. Heart Circ. Physiol. 2006;290:H813–H822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16172164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyamoto T, Dubin AE, Petrus MJ, Patapoutian A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One. 2009;4:e7596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2764051</ArticleId>
            <ArticleId IdType="pubmed">19893614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharya MR, et al.  Radial stretch reveals distinct populations of mechanosensitive mammalian somatosensory neurons. Proc. Natl. Acad. Sci. USA. 2008;105:20015–20020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2604979</ArticleId>
            <ArticleId IdType="pubmed">19060212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Logu F, et al.  Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice. J. Clin. Invest. 2019;129:5424–5441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6877331</ArticleId>
            <ArticleId IdType="pubmed">31487269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS nano. 2009;3:16–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19206243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaMotte RH, Shain CN, Simone DA, Tsai EF. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J. Neurophysiol. 1991;66:190–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1919666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melo-Carrillo A, et al.  Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Adelta) But Not Unmyelinated (C) Meningeal Nociceptors. J. Neurosci. 2017;37:10587–10596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5666582</ArticleId>
            <ArticleId IdType="pubmed">28972120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weidner C, et al.  Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study. J. Invest. Dermatol. 2000;115:1015–1020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11121135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murinson BB, Hoffman PN, Banihashemi MR, Meyer RA, Griffin JW. C-fiber (Remak) bundles contain both isolectin B4-binding and calcitonin gene-related peptide-positive axons. J. Comp. Neurol. 2005;484:392–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15770655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziegler EA, Magerl W, Meyer RA, Treede RD. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain. 1999;122:2245–2257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10581220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irannejad R, et al.  Conformational biosensors reveal GPCR signalling from endosomes. Nature. 2013;495:534–538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3835555</ArticleId>
            <ArticleId IdType="pubmed">23515162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazar A. M. et al. G protein-regulated endocytic trafficking of adenylyl cyclase type 9. Elife9, e58039 (2020).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7332294</ArticleId>
            <ArticleId IdType="pubmed">32515353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng G. E., Pessino V., Huang B., von Zastrow M. Spatial decoding of endosomal cAMP signals by a metastable cytoplasmic PKA network. Nat. Chem. Biol.17, 558–566 (2021).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8084946</ArticleId>
            <ArticleId IdType="pubmed">33649598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet. Neurol. 2009;8:679–690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19539239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullin K, et al.  Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. Neurology. 2020;94:e2121–e2125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7526667</ArticleId>
            <ArticleId IdType="pubmed">31932515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo G, et al.  Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyri din-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine. J. Med. Chem. 2012;55:10644–10651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23153230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manoukian R, et al.  Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking. J. Headache Pain. 2019;20:44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6734291</ArticleId>
            <ArticleId IdType="pubmed">31039731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwan KY, et al.  TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron. 2006;50:277–289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16630838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skarnes WC, et al.  A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474:337–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3572410</ArticleId>
            <ArticleId IdType="pubmed">21677750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guan Z, et al.  Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat. Neurosci. 2016;19:94–101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4703328</ArticleId>
            <ArticleId IdType="pubmed">26642091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zurborg S, et al.  Generation and characterization of an Advillin-Cre driver mouse line. Mol. Pain. 2011;7:66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3185264</ArticleId>
            <ArticleId IdType="pubmed">21906401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods. 2007;39:175–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17695343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2893951</ArticleId>
            <ArticleId IdType="pubmed">20613859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6877845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watabe K, et al.  Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J. Neurosci. Res. 1995;41:279–290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7650763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watabe K, et al.  Tissue culture methods to study neurological disorders: establishment of immortalized Schwann cells from murine disease models. Neuropathology. 2003;23:68–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12722929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J. Pain. 2006;7:908–914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17157777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon WJ. Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 1980;20:441–462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7387124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 1994;53:55–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7990513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elliott MB, Oshinsky ML, Amenta PS, Awe OO, Jallo JI. Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury. Headache. 2012;52:966–984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4105160</ArticleId>
            <ArticleId IdType="pubmed">22568499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tao Y. Isolation and culture of Schwann cells. Methods Mol. Biol. 2013;1018:93–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23681620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nehme R, et al.  Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS One. 2017;12:e0175642.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5398546</ArticleId>
            <ArticleId IdType="pubmed">28426733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan Q, et al.  Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells. J. Biol. Chem. 2018;293:7466–7473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5949987</ArticleId>
            <ArticleId IdType="pubmed">29523687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Namkung Y, et al.  Monitoring G protein-coupled receptor and beta-arrestin trafficking in live cells using enhanced bystander BRET. Nat. Commun. 2016;7:12178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4942582</ArticleId>
            <ArticleId IdType="pubmed">27397672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiefari J, et al.  Living Free-Radical Polymerization by Reversible Addition−Fragmentation Chain Transfer:  The RAFT Process. Macromolecules. 1998;31:5559–5562.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
